Calcipotriene NDC 51672-4154

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-4154Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-4154Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51672-4154-3	51672415403	1 TUBE in 1 CARTON (51672-4154-3) / 60 g in 1 TUBEMarketed from Mar 24, 2010
51672-4154-4	51672415404	1 TUBE in 1 CARTON (51672-4154-4) / 120 g in 1 TUBEMarketed from Mar 24, 2010
51672-4154-5	51672415405	10 TUBE in 1 CARTON (51672-4154-5) / 5 g in 1 TUBEMarketed from Mar 24, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — .05 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090633
Marketing start: Mar 24, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 51672-4154_5698a2a4-f8fb-0b4b-e063-6394a90ab60cSPL ID 5698a2a4-f8fb-0b4b-e063-6394a90ab60cSPL set ID 277d843a-0ea9-429d-813d-49ed72dafb64RxCUI 198373UNII 143NQ3779B
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672415403 followed by a unit qualifier and the quantity

Package 51672-4154-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 14, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Calcipotriene ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090633

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090633
Product	Strength	Form · route	Labeler	Product NDC
Calcitrenecalcipotriene	Calcipotriene .05 mg/g	OintmentTopical	Sun Pharmaceutical Industries, Inc.	51672-5278
Calcipotriene	Calcipotriene 50 ug/g	OintmentTopical	Glenmark Pharmaceuticals Inc., USA	68462-310